Amerisource Recalls bupropion Hydrochloride Tablets for Dissolution Failure
Amerisource Health Services is recalling 2,626 bottles of bupropion hydrochloride extended-release tablets due to failed dissolution specifications.
- Product
- buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03
- Category
- Drug
- Distribution
- Distributed nationwide